| NCT07081997 | A Phase 3 Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism | NOT_YET_RECRUITING | PHASE3 | 2025-11 | 2027-12 | 2026-12 |
| NCT06732895 | A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia. | RECRUITING | PHASE2 | 2024-12-10 | 2027-01 | 2026-12 |
| NCT06433557 | A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-07-26 | 2027-09 | 2025-09 |
| NCT06079398 | A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia | RECRUITING | PHASE2 | 2024-01-23 | 2027-03 | 2026-03 |
| NCT05980598 | TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma | TERMINATED | PHASE2 | 2023-09-29 | 2025-03-28 | 2025-03-28 |
| NCT05929807 | A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia | ENROLLING_BY_INVITATION | PHASE2, PHASE3 | 2023-06-21 | 2039-03 | 2039-01 |
| NCT05598320 | A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia | ACTIVE_NOT_RECRUITING | PHASE2, PHASE3 | 2023-03-03 | 2025-08 | 2024-08-09 |
| NCT05690386 | A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-02-15 | 2027-12 | 2024-10-18 |
| NCT05081609 | A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies | RECRUITING | PHASE1, PHASE2 | 2022-01-11 | 2029-08 | 2027-08 |
| NCT05246033 | A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-01-05 | 2024-03 | 2023-03-15 |
| NCT05171855 | A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency | COMPLETED | PHASE3 | 2021-12-16 | 2024-12-23 | 2024-12-23 |
| NCT04799054 | A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-03-18 | 2026-03 | 2026-01 |
| NCT04701203 | A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism | COMPLETED | PHASE3 | 2021-02-16 | 2025-01-21 | 2022-01-12 |
| NCT04615273 | A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency | COMPLETED | PHASE3 | 2020-12-03 | 2023-12-01 | 2023-11-02 |
| NCT04085523 | A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia | COMPLETED | PHASE2 | 2020-06-24 | 2024-10-01 | 2022-09-27 |
| NCT04009291 | A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism | COMPLETED | PHASE2 | 2019-08-27 | 2025-04-17 | 2020-03-06 |
| NCT03344458 | A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial | COMPLETED | PHASE3 | 2017-12-19 | 2023-02-21 | 2023-02-21 |
| NCT03305016 | A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency | COMPLETED | PHASE3 | 2017-11-13 | 2019-03-19 | 2019-03-19 |
| NCT02781727 | A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) | COMPLETED | PHASE3 | 2016-12-13 | 2019-01-17 | 2019-01-17 |
| NCT03803163 | A Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male Volunteers | TERMINATED | PHASE1 | 2015-01 | 2015-06 | 2015-06 |
| NCT01947907 | Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) | COMPLETED | PHASE2 | 2013-07 | 2015-09 | 2015-07 |
| NCT01247675 | A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency | COMPLETED | PHASE2 | 2010-11 | 2011-05 | 2011-05 |
| NCT01010425 | Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH) | COMPLETED | PHASE1 | 2009-11 | 2010-05 | 2010-02 |